The Discounted Cash Flow (DCF) valuation of Genmab A/S (GMAB.CO) is 1,116.48 DKK. With the latest stock price at 1,758.50 DKK, the upside of Genmab A/S based on DCF is -36.5%.
Based on the latest price of 1,758.50 DKK and our DCF valuation, Genmab A/S (GMAB.CO) is a sell. selling GMAB.CO stocks now will result in a potential gain of 36.5%.
| Range | Selected | |
| WACC / Discount Rate | 6.5% - 9.2% | 7.8% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 720.60 - 2,055.37 | 1,116.48 |
| Upside | -59.0% - 16.9% | -36.5% |